10 Feb Catalent
Catalent Cell & Gene Therapy is an industry-leading technology, development, manufacturing, and analytical testing partner for advanced therapeutics. With deep expertise in viral vector development, scale-up and manufacturing for gene therapies and viral vaccines, Catalent is a full-service partner for Plasmid DNA, Adeno-associated Virus (AAV), Lentivirus and other viral vectors, and oncolytic viruses. Its comprehensive Cell Therapy portfolio includes a wide range of expertise across a variety of cell types including CAR-T, TCR, TILs, NKs, iPSCs, and MSCs. As an experienced and innovative partner, it has a global network of dedicated development, clinical and commercial manufacturing facilities, including an EMA- and FDA-licensed viral vector facility, fill/finish capabilities located in the U.S. and Europe and full service analytical testing. With integrated solutions for plasmid DNA, viral vectors and autologous and allogeneic cell therapies through clinical trial packaging and logistics, Catalent can provide full supply chain control as well as integrated or standalone analytical support to enable innovators to get their advanced therapies to patients faster.
